{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T13:40:31Z","timestamp":1790948431133,"version":"4.1.0"},"reference-count":48,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,4,29]],"date-time":"2025-04-29T00:00:00Z","timestamp":1745884800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["32141002"],"award-info":[{"award-number":["32141002"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002365","name":"China Agricultural University","doi-asserted-by":"publisher","award":["PC2023A01002"],"award-info":[{"award-number":["PC2023A01002"]}],"id":[{"id":"10.13039\/501100002365","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013290","name":"National Key Research and Development Program of China Stem Cell and Translational Research","doi-asserted-by":"publisher","award":["2022YFD1800400"],"award-info":[{"award-number":["2022YFD1800400"]}],"id":[{"id":"10.13039\/501100013290","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["eBioMedicine"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1016\/j.ebiom.2025.105754","type":"journal-article","created":{"date-parts":[[2025,5,13]],"date-time":"2025-05-13T12:11:30Z","timestamp":1747138290000},"page":"105754","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["Antifungal agent tavaborole as a potential broad-spectrum serine and metallo-\u03b2-lactamases inhibitor"],"prefix":"10.1016","volume":"116","author":[{"given":"Yan","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siyuan","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhaoju","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huangwei","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ning","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-7085-4305","authenticated-orcid":false,"given":"Yunrui","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shangshang","family":"Qin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jifeng","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongli","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5825-5397","authenticated-orcid":false,"given":"Junfeng","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Congming","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianzhong","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shizhen","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5928-9377","authenticated-orcid":false,"given":"Yang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dejun","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ebiom.2025.105754_bib1","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1038\/s41579-019-0159-8","article-title":"Interplay between \u03b2-lactamases and new \u03b2-lactamase inhibitors","volume":"17","author":"Bush","year":"2019","journal-title":"Nat Rev Microbiol"},{"key":"10.1016\/j.ebiom.2025.105754_bib2","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1023\/A:1012272403776","article-title":"The development of \u03b2-lactam antibiotics in response to the evolution of \u03b2-lactamases","volume":"18","author":"Essack","year":"2001","journal-title":"Pharm Res"},{"key":"10.1016\/j.ebiom.2025.105754_bib3","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms12406","article-title":"Structural basis of metallo-\u03b2-lactamase, serine-\u03b2-lactamase and penicillin-binding protein inhibition by cyclic boronates","volume":"7","author":"Brem","year":"2016","journal-title":"Nat Commun"},{"key":"10.1016\/j.ebiom.2025.105754_bib4","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/S1473-3099(09)70054-4","article-title":"The real threat of Klebsiella pneumoniae carbapenemase-producing bacteria","volume":"9","author":"Nordmann","year":"2009","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.ebiom.2025.105754_bib43","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1128\/AAC.11.5.852","article-title":"Clavulanic acid: a beta lactamase inhibiting beta lactam from Streptomyces clavuligerus","volume":"11","author":"Reading","year":"1977","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ebiom.2025.105754_bib44","doi-asserted-by":"crossref","first-page":"577","DOI":"10.2165\/00003495-198733060-00003","article-title":"Sulbactam\/ampicillin: a review of its antibacterial activity, pharmacokinetic properties, and therapeutic use","volume":"33","author":"Campoli-Richards","year":"1987","journal-title":"Drugs"},{"key":"10.1016\/j.ebiom.2025.105754_bib45","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1093\/jac\/26.4.598","article-title":"Piperacillin\/tazobactam and ticarcillin\/clavulanic add against resistant Enterobacteriaceae","volume":"26","author":"Kempers","year":"1990","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ebiom.2025.105754_bib46","doi-asserted-by":"crossref","first-page":"2463","DOI":"10.1093\/jac\/dks246","article-title":"Intrapulmonary penetration of ceftolozane\/tazobactam and piperacillin\/tazobactam in healthy adult subjects","volume":"67","author":"Chandorkar","year":"2012","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ebiom.2025.105754_bib47","doi-asserted-by":"crossref","first-page":"11663","DOI":"10.1073\/pnas.1205073109","article-title":"Avibactam is a covalent, reversible, non-\u03b2-lactam \u03b2-lactamase inhibitor","volume":"109","author":"Ehmann","year":"2012","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.ebiom.2025.105754_bib23","doi-asserted-by":"crossref","first-page":"3682","DOI":"10.1021\/acs.jmedchem.5b00127","article-title":"Discovery of a cyclic boronic acid \u03b2-lactamase inhibitor (RPX7009) with utility vs class A serine carbapenemases","volume":"58","author":"Hecker","year":"2015","journal-title":"J Med Chem"},{"key":"10.1016\/j.ebiom.2025.105754_bib48","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1007\/s40265-017-0851-9","article-title":"Imipenem\u2013relebactam and meropenem\u2013vaborbactam: two novel carbapenem-\u03b2-lactamase inhibitor combinations","volume":"78","author":"Zhanel","year":"2018","journal-title":"Drugs"},{"key":"10.1016\/j.ebiom.2025.105754_bib5","doi-asserted-by":"crossref","first-page":"7491","DOI":"10.1021\/acs.jmedchem.9b01976","article-title":"Discovery of cyclic boronic acid QPX7728, an ultrabroad-spectrum inhibitor of serine and metallo-\u03b2-lactamases","volume":"63","author":"Hecker","year":"2020","journal-title":"J Med Chem"},{"key":"10.1016\/j.ebiom.2025.105754_bib6","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.cbpa.2019.03.001","article-title":"Will morphing boron-based inhibitors beat the \u03b2-lactamases?","volume":"50","author":"Krajnc","year":"2019","journal-title":"Curr Opin Chem Biol"},{"key":"10.1016\/j.ebiom.2025.105754_bib8","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1056\/NEJMoa2304748","article-title":"Cefepime\u2013taniborbactam in complicated urinary tract infection","volume":"390","author":"Wagenlehner","year":"2024","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ebiom.2025.105754_bib49","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1128\/AAC.01963-19","article-title":"VNRX-5133 (Taniborbactam), a broad-spectrum inhibitor of serine- and metallo-\u03b2-lactamases, restores activity of cefepime in enterobacterales and Pseudomonas aeruginosa","volume":"64","author":"Hamrick","year":"2020","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ebiom.2025.105754_bib50","doi-asserted-by":"crossref","first-page":"8544","DOI":"10.1021\/acs.jmedchem.9b00911","article-title":"Bicyclic boronate VNRX-5133 inhibits metallo- and serine-\u03b2-lactamases","volume":"62","author":"Krajnc","year":"2019","journal-title":"J Med Chem"},{"key":"10.1016\/j.ebiom.2025.105754_bib7","article-title":"A phase 1 study of the safety, tolerability, and pharmacokinetics of multiple doses of the beta-lactamase inhibitor xeruborbactam alone and in combination meropenem in healthy adult subjects","volume":"9","author":"Griffith","year":"2022","journal-title":"Open Forum Infect Dis"},{"key":"10.1016\/j.ebiom.2025.105754_bib9","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.1038\/s41587-020-00751-0","article-title":"FDALabel for drug repurposing studies and beyond","volume":"38","author":"Fang","year":"2020","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.ebiom.2025.105754_bib10","series-title":"CLSI supplement M100","author":"Abdulrazzaq","year":"2023"},{"key":"10.1016\/j.ebiom.2025.105754_bib11","first-page":"1","article-title":"Bismuth antimicrobial drugs serve as broad-spectrum metallo-\u03b2-lactamase inhibitors","volume":"9","author":"Wang","year":"2018","journal-title":"Nat Commun"},{"key":"10.1016\/j.ebiom.2025.105754_bib12","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.eng.2023.06.012","article-title":"Dual effects of feed-additive-derived chelerythrine in combating mobile colistin resistance","volume":"32","author":"Song","year":"2024","journal-title":"Engineering"},{"key":"10.1016\/j.ebiom.2025.105754_bib13","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/jac\/dkg301","article-title":"Synergy, antagonism, and what the chequerboard puts between them","volume":"52","author":"Odds","year":"2003","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ebiom.2025.105754_bib14","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1093\/jac\/dkae074","article-title":"Synergistic effects of ceftazidime\/avibactam combined with meropenem in a murine model of infection with KPC-producing Klebsiella pneumoniae","volume":"79","author":"Zheng","year":"2024","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ebiom.2025.105754_bib15","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1021\/ct700301q","article-title":"Grgmacs 4: algorithms for highly efficient, load-balanced, and scalable molecular simulation","volume":"4","author":"Hess","year":"2008","journal-title":"J Chem Theory Comput"},{"key":"10.1016\/j.ebiom.2025.105754_bib18","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1177\/1091581814545245","article-title":"Tavaborole, a novel boron-containing small molecule for the topical treatment of onychomycosis, is noncarcinogenic in 2-year carcinogenicity studies","volume":"33","author":"Ciaravino","year":"2014","journal-title":"Int J Toxicol"},{"key":"10.1016\/j.ebiom.2025.105754_bib19","doi-asserted-by":"crossref","first-page":"2527","DOI":"10.1097\/CCM.0000000000000514","article-title":"Vancomycin-associated nephrotoxicity in the critically ill: a retrospective multivariate regression analysis","volume":"42","author":"Hanrahan","year":"2014","journal-title":"Crit Care Med"},{"issue":"10","key":"10.1016\/j.ebiom.2025.105754_bib20","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1038\/s41579-024-01054-w","article-title":"ESKAPE pathogens: antimicrobial resistance, epidemiology, clinical impact and therapeutics","volume":"22","author":"Miller","year":"2024","journal-title":"Nat Rev Microbiol"},{"key":"10.1016\/j.ebiom.2025.105754_bib21","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1016\/j.tim.2016.06.009","article-title":"Antibiotic adjuvants: rescuing antibiotics from resistance","volume":"24","author":"Wright","year":"2016","journal-title":"Trends Microbiol"},{"key":"10.1016\/j.ebiom.2025.105754_bib22","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2021.697180","article-title":"QPX7728, an ultra-broad-spectrum B-lactamase inhibitor for intravenous and oral therapy: overview of biochemical and microbiological characteristics","volume":"12","author":"Lomovskaya","year":"2021","journal-title":"Front Microbiol"},{"key":"10.1016\/j.ebiom.2025.105754_bib24","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1038\/nrmicro727","article-title":"Opinion \u2013 anti-infectives: where will new antibiotics come from?","volume":"1","author":"Walsh","year":"2003","journal-title":"Nat Rev Microbiol"},{"key":"10.1016\/j.ebiom.2025.105754_bib25","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1038\/s41579-022-00820-y","article-title":"Molecular mechanisms of antibiotic resistance revisited","volume":"21","author":"Darby","year":"2023","journal-title":"Nat Rev Microbiol"},{"key":"10.1016\/j.ebiom.2025.105754_bib26","doi-asserted-by":"crossref","first-page":"9543","DOI":"10.1039\/C5CC02594J","article-title":"Ebselen as a potent covalent inhibitor of New Delhi metallo-\u03b2-lactamase (NDM-1)","volume":"51","author":"Chiou","year":"2015","journal-title":"Chem Commun"},{"key":"10.1016\/j.ebiom.2025.105754_bib27","doi-asserted-by":"crossref","first-page":"11362","DOI":"10.1021\/ja303579d","article-title":"New Delhi metallo-\u03b2-lactamase: structural insights into \u03b2-lactam recognition and inhibition","volume":"134","author":"King","year":"2012","journal-title":"J Am Chem Soc"},{"key":"10.1016\/j.ebiom.2025.105754_bib28","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijantimicag.2024.107211","article-title":"Identification of a novel Providencia species showing multi-drug-resistant in three patients with hospital-acquired infection","volume":"64","author":"Yang","year":"2024","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.ebiom.2025.105754_bib29","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.jorganchem.2018.03.017","article-title":"Benzoboroxoles: synthesis and applications in medicinal chemistry","volume":"865","author":"Mereddy","year":"2018","journal-title":"J Organomet Chem"},{"key":"10.1016\/j.ebiom.2025.105754_bib30","doi-asserted-by":"crossref","first-page":"5224","DOI":"10.1021\/cr500642d","article-title":"Recent developments in the chemistry and biological applications of benzoxaboroles","volume":"115","author":"Adamczyk-Wo\u017aniak","year":"2015","journal-title":"Chem Rev"},{"key":"10.1016\/j.ebiom.2025.105754_bib31","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1080\/13543776.2018.1473379","article-title":"Benzoxaborole compounds for therapeutic uses: a patent review (2010- 2018)","volume":"28","author":"Nocentini","year":"2018","journal-title":"Expert Opin Ther Pat"},{"key":"10.1016\/j.ebiom.2025.105754_bib32","doi-asserted-by":"crossref","first-page":"6765","DOI":"10.1021\/acs.jmedchem.9b00736","article-title":"Design, synthesis, and structure-activity relationship of 7-propanamide benzoxaboroles as potent anticancer agents","volume":"62","author":"Zhang","year":"2019","journal-title":"J Med Chem"},{"key":"10.1016\/j.ebiom.2025.105754_bib33","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1128\/CMR.05035-11","article-title":"Carbapenemases in Klebsiella pneumoniae and other Enterobacteriaceae: an evolving crisis of global dimensions","volume":"25","author":"Tzouvelekis","year":"2012","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.ebiom.2025.105754_bib34","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1517\/14656566.2012.681779","article-title":"New therapeutic options for onychomycosis","volume":"13","author":"Gupta","year":"2012","journal-title":"Expert Opin Pharmacother"},{"key":"10.1016\/j.ebiom.2025.105754_bib35","doi-asserted-by":"crossref","first-page":"7709","DOI":"10.1039\/D1CC03026D","article-title":"Design and enantioselective synthesis of 3-(\u03b1-acrylic acid) benzoxaboroles to combat carbapenemase resistance","volume":"57","author":"Xiao","year":"2021","journal-title":"Chem Commun"},{"key":"10.1016\/j.ebiom.2025.105754_bib36","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1021\/cr100093b","article-title":"Natural and synthetic small boron-containing molecules as potential inhibitors of bacterial and fungal quorum sensing","volume":"111","author":"Dembitsky","year":"2011","journal-title":"Chem Rev"},{"key":"10.1016\/j.ebiom.2025.105754_bib37","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1016\/j.bmc.2007.10.075","article-title":"Structure-based optimization of cephalothin-analogue boronic acids as \u03b2-lactamase inhibitors","volume":"16","author":"Morandi","year":"2008","journal-title":"Bioorganic Med Chem"},{"key":"10.1016\/j.ebiom.2025.105754_bib38","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1128\/CMR.00037-09","article-title":"Three decades of \u03b2-lactamase inhibitors","volume":"23","author":"Drawz","year":"2010","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.ebiom.2025.105754_bib39","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1111\/j.1749-6632.2012.06796.x","article-title":"Metallo-\u03b2-lactamase structure and function","volume":"1277","author":"Palzkill","year":"2013","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.ebiom.2025.105754_bib40","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.jaad.2015.04.010","article-title":"Efficacy and safety of tavaborole topical solution, 5%, a novel boron-based antifungal agent, for the treatment of toenail onychomycosis: results from 2 randomized phase-III studies","volume":"73","author":"Elewski","year":"2015","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.ebiom.2025.105754_bib41","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1177\/1091581816641938","article-title":"Tavaborole, a novel boron-containing small molecule pharmaceutical agent for topical treatment of onychomycosis: II. Prenatal and postnatal developmental toxicity and maternal function study","volume":"35","author":"Ciaravino","year":"2016","journal-title":"Int J Toxicol"},{"key":"10.1016\/j.ebiom.2025.105754_bib42","doi-asserted-by":"crossref","DOI":"10.1186\/s13568-022-01488-6","article-title":"Drug synergy discovery of tavaborole and aminoglycosides against Escherichia coli using high throughput screening","volume":"12","author":"Liu","year":"2022","journal-title":"AMB Express"}],"container-title":["eBioMedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352396425001987?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352396425001987?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,11]],"date-time":"2025-06-11T08:17:40Z","timestamp":1749629860000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352396425001987"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":48,"alternative-id":["S2352396425001987"],"URL":"https:\/\/doi.org\/10.1016\/j.ebiom.2025.105754","relation":{},"ISSN":["2352-3964"],"issn-type":[{"value":"2352-3964","type":"print"}],"subject":[],"published":{"date-parts":[[2025,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Antifungal agent tavaborole as a potential broad-spectrum serine and metallo-\u03b2-lactamases inhibitor","name":"articletitle","label":"Article Title"},{"value":"eBioMedicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ebiom.2025.105754","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"105754"}}